Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well FR901228 works in treating patients with
unresectable recurrent or metastatic squamous cell carcinoma (cancer) of the head and neck.
Drugs used in chemotherapy such as FR901228 work in different ways to stop tumor cells from
dividing so they stop growing or die.